119 related articles for article (PubMed ID: 36828346)
21. Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells.
Lu Y; Zi X; Zhao Y; Pollak M
Biochem Biophys Res Commun; 2004 Jan; 313(3):709-15. PubMed ID: 14697248
[TBL] [Abstract][Full Text] [Related]
22. VEPH1 suppresses the progression of gastric cancer by regulating the Hippo-YAP signalling pathway.
Nie X; Zhou Z; Chen Y; Chen S; Chen Y; Lei J; Wu X; He S
Dig Liver Dis; 2024 Jan; 56(1):187-197. PubMed ID: 37244789
[TBL] [Abstract][Full Text] [Related]
23. Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia.
Yip WK; Choo CW; Leong VC; Leong PP; Jabar MF; Seow HF
APMIS; 2013 Oct; 121(10):954-66. PubMed ID: 23992303
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
[TBL] [Abstract][Full Text] [Related]
25. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
[TBL] [Abstract][Full Text] [Related]
26. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
[TBL] [Abstract][Full Text] [Related]
27. ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases.
Spencer KS; Graus-Porta D; Leng J; Hynes NE; Klemke RL
J Cell Biol; 2000 Jan; 148(2):385-97. PubMed ID: 10648571
[TBL] [Abstract][Full Text] [Related]
28. Cyclic stretch activates p38 SAPK2-, ErbB2-, and AT1-dependent signaling in bladder smooth muscle cells.
Nguyen HT; Adam RM; Bride SH; Park JM; Peters CA; Freeman MR
Am J Physiol Cell Physiol; 2000 Oct; 279(4):C1155-67. PubMed ID: 11003596
[TBL] [Abstract][Full Text] [Related]
29. Gab1 signaling is regulated by EGF receptor sorting in early endosomes.
Kostenko O; Tsacoumangos A; Crooks D; Kil SJ; Carlin C
Oncogene; 2006 Oct; 25(50):6604-17. PubMed ID: 16715136
[TBL] [Abstract][Full Text] [Related]
30. EGFR and ErbB2 differentially regulate Raf-1 translocation and activation.
Zhang L; Bewick M; Lafrenie RM
Lab Invest; 2002 Jan; 82(1):71-8. PubMed ID: 11796827
[TBL] [Abstract][Full Text] [Related]
31. Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns.
Wosikowski K; Schuurhuis D; Johnson K; Paull KD; Myers TG; Weinstein JN; Bates SE
J Natl Cancer Inst; 1997 Oct; 89(20):1505-15. PubMed ID: 9337347
[TBL] [Abstract][Full Text] [Related]
32. Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.
Piiper A; Elez R; You SJ; Kronenberger B; Loitsch S; Roche S; Zeuzem S
J Biol Chem; 2003 Feb; 278(9):7065-72. PubMed ID: 12496267
[TBL] [Abstract][Full Text] [Related]
33. Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to Taxol.
Kunz C; Borghouts C; Buerger C; Groner B
Mol Cancer Res; 2006 Dec; 4(12):983-98. PubMed ID: 17189388
[TBL] [Abstract][Full Text] [Related]
34. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
35. Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner.
Park GB; Ko HS; Kim D
Mol Med Rep; 2017 Aug; 16(2):1826-1836. PubMed ID: 28627617
[TBL] [Abstract][Full Text] [Related]
36. Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway.
Feng H; Jia XM; Gao NN; Tang H; Huang W; Ning N
Cell Cycle; 2019 Nov; 18(21):2860-2875. PubMed ID: 31599708
[TBL] [Abstract][Full Text] [Related]
37. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
Vacca F; Bagnato A; Catt KJ; Tecce R
Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
[TBL] [Abstract][Full Text] [Related]
38. Role of ErbB2 in the prostaglandin E₂-induced enhancement of the mitogenic response to epidermal growth factor in cultured hepatocytes.
Ødegård J; Aasrum M; Tveteraas IH; Bharath SP; Sandnes D; Christoffersen T
Biochem Biophys Res Commun; 2012 May; 421(2):255-60. PubMed ID: 22503980
[TBL] [Abstract][Full Text] [Related]
39. Interaction and inhibitory cross-talk between endothelin and ErbB receptors in the adult heart.
Chung KY; Walker JW
Mol Pharmacol; 2007 Jun; 71(6):1494-502. PubMed ID: 17332141
[TBL] [Abstract][Full Text] [Related]
40. Direct binding of Copine3 with Jab1 activates downstream ErbB2 signaling and motility in SKBr3 breast cancer cells.
Choi HY; Park N; Na JB; Ko ES; Park JY; Yoo JC
Oncol Rep; 2016 Feb; 35(2):1147-52. PubMed ID: 26719032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
